KRAS and colorectal carcinoma: Accounting for BRAF and KRAS applied concurrently with the TNM staging system was shown to improve the prognostic ability from a 0.61–0.68 to 0.63–0.71 concordance index (a performance measurement in survival analysis) for stage II and III CRC patients [21].